NWR Communications

Thanks to the The Melbourne Mining Club Steering Committee for putting on another engaging 'Cutting Edge' event last night. It was great to listen to the presentations delivered by Mark English from Auric Mining Limited (ASX:AWJ), Philippa Leggat from Critica Limited and Jon Price from Richmond Vanadium Technology.

We've confirmed high-grade uranium mineralisation at our 100%-owned Eridani Uranium Project (EL 5851) on South Australia's Eyre Peninsula. A recent reconnaissance sampling program identified significant carnotite mineralisation, with pXRF results showing up to 9,250 ppm U. Eridani is strategically located on the eastern Eyre Peninsula, proximal to significant uranium deposits including Alligator Energy’s Samphire Project. All samples have been submitted for laboratory analysis, with results expected in October. We aim to undertake additional exploration plans including mapping, sampling, and reviewing publicly available geophysical data to assist in potential drilling campaigns. Our Kookaburra Graphite Project Pre-Feasibility Study remains ahead of schedule and is due for completion in October. Read the full ASX Announcement here: https://lnkd.in/g25DA4j7 #LincolnMinerals #LML #uranium #graphite #UraniumExploration #EridaniProject #EyrePeninsula #Carnotite #MiningAustralia #UraniumDiscovery #CriticalMinerals #MineralExploration #SustainableMining #ResourceDevelopment #CleanEnergy #ASXNews #MiningNews 

United H2 Limited (UHL) has been featured on the front page of The Weekend Australian's Business Review, one of the nation's most-read financial publications. In the article, UHL's CEO, Will Davidson, provides an update on the Company's listing plans, the appointment of Mark Bouris to the Board, and a recent investment by one of Australia's most respected bankers/economists. Key Highlights:  - UHL has appointed one of Australia's leading businessmen, Mark Bouris AM (Order of Australia), as a Non-Executive Director. - UHL has bolstered its Board ahead of a targeted initial public offering in late 2024 or early 2025. - UHL has secured a material investment from former Reserve Bank stalwart, and Deutsche Bank investment strategy director, Don Stammer. - Broking house, Canaccord Genuity, is undertaking research and diligence ahead of a potential IPO. - Law firm, Hall & Wilcox, is on deck to assist, alongside accounting firms HLB Mann Judd and RSM. Support from one of Australia's leading entrepreneurs and investment bankers showcases that UHL is continuing to build shareholder value. Click the links below to invest in the Company's pre-IPO capital raise or read the article. Read article 👉 https://lnkd.in/eJqXHj68 Invest 👉 https://lnkd.in/gvdKuvbD #CleanEnergy #Hydrogen #RenewableEnergy #GreenHydrogen #SustainableEnergy #GreenEnergy #HydrogenFuel #EnergyInvestment #HydrogenEconomy #SolarEnergy #HydrogenTechnology #finance #HydrogenFuture #fuelcells #HydrogenCars #HydrogenRevolution #SustainableInvestment #HydrogenPower #ClimateAction #EcoInvesting #HydrogenVehicle #GreenInvesting #innovation #impactinvesting #CleanTech #IPO #capital #equity #ECM #capitalraise

This morning we announced the completion of our maiden shallow due diligence drilling program at the Raptor REE Project in Brazil. Assay results indicate a compelling presence of REEs both at surface and within the shallow saprolite, with all holes ending in mineralisation suggesting substantial potential upside at depth, as is evident at other nearby Caldeira-style clay-hosted REE deposits. Results confirm that REE mineralisation is now evident across all three Raptor Project areas (the Pina Colada, Portao Verde and Pinheirinho prospects). Significantly higher-value Neodymium-Praseodymium rare earths were also confirmed, with individual drill holes showing up to 35% Nd+Pr ratios. Hear our Executive Chairman Julian Babarczy discuss 📹

WRAP 🗞 Blue Ocean Equities initiates on Larvotto Resources Limited with +100% upside; Neurotech International Ltd success in NTI164 trial; Lotus Resources’ thick uranium hits at Letlhakane 📰 Read here: https://lnkd.in/edqH8vVC Subscribe to the Wrap: https://lnkd.in/e_Xz57yu

Great to connect with investors and supporters over the past couple of weeks in Melbourne and Sydney. Our CEO Ebbe Dommisse discussed Iondrive’s innovative DES #battery #recycling #technology, highlighting its unique environmental benefits, recent trial successes, and the strategic path towards commercialisation, including partnerships and opportunities within the growing European market driven by regulatory tailwinds. #sustainability #BatteryRecycling

Cue Energy has returned $21M to shareholders in FY24, with a total dividend of $0.03 per share, including a final 1 cent dividend announced with our FY24 results. We're committed to sustainable returns while investing in future growth. #CueEnergy #CUE #Dividends #ASX #ShareholderReturns

NTI164 has successfully reversed immune dysregulation in children with PANDAS/PANS, aligning with the significant clinical improvements seen in our Phase I/II trial at 12 weeks. NTI164 positively modifies immune cell function and gene translation, including the reversal of dysregulated pathways such as MECP2, associated with Rett Syndrome. This discovery highlights NTI164’s potential to normalise immune function and gene translation profiles, offering a promising disease-modifying treatment for PANDAS/PANS. Additional patent applications have been filed, with genomic analysis underway. Professor Russell Dale, Professor of Paediatric Neurology, University of Sydney and Children’s Hospital at Westmead and Co-Principal investigator of the NTIPANS1 trial said "My research group hypothesises PANDAS/PANS is the result of gene-environment (epigenetic) neuroimmune dysregulation leading to persistent or progressive neuroinflammation. Currently most patients are symptomatically managed, whereas NTI164’s anti-neuroinflammatory properties have now been shown to induce important epigenetic and proteomic changes in immune cells collected from patients at baseline (day zero) and after 12 weeks of treatment. This data is exciting as it demonstrates that the biological aspects of this debilitating condition can be modified by NTI164, including immune and epigenetic dysregulation, improving overall health and functional outcomes of children with PANDAS/PANS. We eagerly await further genomic analysis from these same patients.” Read the full ASX Announcement here: https://lnkd.in/guG3kgfa #NTI164 #PANDAS #PANS #Neurotech #NTI #Biotech #ClinicalTrials #ImmuneDysregulation #GeneTranslation #RettSyndrome #PediatricHealth #PharmaInnovation #ASX #OrphanDrugs #Proteomics #GenomicAnalysis #Healthcare Ontario Rett Syndrome Association PANDAS Network Official- PANS PANDAS UK PANDAS PPN @pansaustralia  @PANDASPANSON @PANDASPPN @PANDASnetwork @PANSPANDASUK

WRAP 🗞 Canaccord’s $3.15/sh PT for West African Resources has 125% upside; Promising results in Imugene Limited lymphoma trial; EQ Resources Limited signs multi-year tungsten offtake: https://buff.ly/4dRL68T

Managing Director Justin Brown caught up with ausbiz to provide an update on our recently announced MOU with Nissan Chemical America Corporation to explore building a facility in Japan to supply high purity manganese sulphate monohydrate to be used in #EV batteries. Justin explains how our current partnership with GM and Stellantis to build a similar facility in the USA may provide the blueprint for a future Japanese facility. Listen to the interview for Justin's take on the long-term viability of manganese for use in EVs and the expansion plans at our Butcherbird project. Watch the full video here 👇  #Element25 #E25 #EVRevolution #SustainableTransport #Manganese #BatteryMaterials #GreenEnergy #CriticalMinerals #FutureOfMobility